LTRNLantern Pharma Inc.

$31M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$14M

Net Income

-$14M

EPS (Diluted)

$-1.31

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$59M

Total Liabilities

$3M

Stockholders' Equity

$56M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$14M	-$13M	-14.6%
Net Income	-$14M	-$12M	-15.3%

LTRN FY 2022 Earnings — Lantern Pharma Inc. Revenue & Financial Results | Market Cap Arena